Skip to content

Categories:

Tag Archives: Food and Drug Administration

Fuad El-Hibri Announces Emergent BioSolutionsAward to Supply BioThrax Anthrax Vaccine to U.S. Government October 14, 2011
Posted in BioDefense, BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, U.S. Food and Drug Administration.
No comments
Emergent BioSolutions’ Investigational Anthrax Vaccine, NuThrax, Granted Fast Track Designation June 10, 2011
Posted in Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, NuThrax, U.S. Food and Drug Administration.
No comments
Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule June 7, 2011
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Food and Drug Administration, Fuad El-Hibri.
No comments
Emergent BioSolutions to Release Third Quarter 2010 Financial Results and Conduct a Conference Call on November 4, 2010 October 23, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Fuad El-Hibri, NYSE, Vaccine.
No comments
Emergent BioSolutions Awarded HHS Contract Valued at up to $186.6 Million to Develop rPA Anthrax Vaccine September 20, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, United States Department of Health and Human Services, Vaccine.
No comments
Emergent BioSolutions Awarded NIAID Contract That Increases Potential Funding to Over $58 Million for Advanced Development of Third Generation Anthrax Vaccine September 10, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Vaccine.
No comments
Emergent BioSolutions Hosts Symposium for Biomedical Research Scholars August 30, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Fuad Elhibri, Scholars Program.
No comments
Emergent Revises Upward 2010 Financial Forecast August 3, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Maryland, United States, Vaccine.
No comments
Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax July 15, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, United States Department of Health and Human Services, Vaccine.
No comments
Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians July 13, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Food and Drug Administration, Fuad El-Hibri, United States Department of Defense, United States Department of Health and Human Services.
No comments
Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments July 7, 2010
Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States, Washington.
No comments
Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland May 18, 2010
Posted in Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Maryland, Tech Council of Maryland, Washington.
No comments
Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young December 16, 2009
Posted in Chief executive officer, Emergent BioSolutions, Ernst & Young Entrepreneur of the Year, Federal government of the United States, Washington.
No comments
Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore November 15, 2009
Posted in Emergent BioSolutions, Fuad El-Hibri, Fuad Elhibri.
No comments